Keith Kerstann

2.7k total citations · 2 hit papers
9 papers, 2.1k citations indexed

About

Keith Kerstann is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Keith Kerstann has authored 9 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Immunology and 3 papers in Genetics. Recurrent topics in Keith Kerstann's work include CAR-T cell therapy research (5 papers), T-cell and B-cell Immunology (4 papers) and Immunotherapy and Immune Responses (4 papers). Keith Kerstann is often cited by papers focused on CAR-T cell therapy research (5 papers), T-cell and B-cell Immunology (4 papers) and Immunotherapy and Immune Responses (4 papers). Keith Kerstann collaborates with scholars based in United States and Poland. Keith Kerstann's co-authors include Nicholas P. Restifo, Douglas C. Palmer, Luca Gattinoni, Steven A. Rosenberg, Paul A. Antony, Christopher A. Klebanoff, Christian S. Hinrichs, Chrystal M. Paulos, Parizad Torabi‐Parizi and Adela R. Cardones and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Keith Kerstann

9 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Central memory self/tumor-reactive CD8 ⁺ T cells confer superior antitumor immunity compared with effector memory T cells

2005 752 citations Christopher A. Klebanoff, Luca Gattinoni et al. Proceedings of the National Academy of Sciences profile →
Tumor-specific Th17-polarized cells eradicate large established melanoma

2008 638 citations Pawel Muranski, Andrea Boni et al. Blood profile →

Peers

Countries citing papers authored by Keith Kerstann

Since Specialization

Citations

This map shows the geographic impact of Keith Kerstann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Kerstann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Kerstann more than expected).

Fields of papers citing papers by Keith Kerstann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Kerstann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Kerstann. The network helps show where Keith Kerstann may publish in the future.

Co-authorship network of co-authors of Keith Kerstann

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Kerstann. A scholar is included among the top collaborators of Keith Kerstann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Kerstann. Keith Kerstann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Directed Engineering of a High-expression Chimeric Transgene as a Strategy for Gene Therapy of Hemophilia A 2009 ·Molecular Therapy ·Christopher B. Doering, Gabriela Denning, (unknown), Bagirath Gangadharan, (unknown), Keith Kerstann, (unknown), H. Trent Spencer	62
2	Tumor-specific Th17-polarized cells eradicate large established melanoma breakdown → 2008 ·Blood ·Pawel Muranski, Andrea Boni, Paul A. Antony, Lydie Cassard, Kari R. Irvine, Andrew Kaiser, Chrystal M. Paulos, Douglas C. Palmer, Christopher E. Touloukian, Krzysztof Ptak, Luca Gattinoni, Claudia Wrzesinski, Christian S. Hinrichs, Keith Kerstann, Lionel Feigenbaum, Chi‐Chao Chan, Nicholas P. Restifo	638
3	IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy 2008 ·Blood ·Christian S. Hinrichs, Rosanne Spolski, Chrystal M. Paulos, Luca Gattinoni, Keith Kerstann, Douglas C. Palmer, Christopher A. Klebanoff, Steven A. Rosenberg, Warren J. Leonard, Nicholas P. Restifo	358
4	MITOCHIP assessment of differential gene expression in the skeletal muscle of Ant1 knockout mice: Coordinate regulation of OXPHOS, antioxidant, and apoptotic genes 2008 ·Biochimica et Biophysica Acta (BBA) - Bioenergetics ·(unknown), Paweł Golik, Deborah G. Murdock, Shawn Levy, Keith Kerstann, Pınar Coşkun, (unknown), Douglas C. Wallace	24
5	Development of a Novel Recombinant Factor VIII Product through Transgene Engineering and Lentiviral-Driven Expression 2008 ·Blood ·Keith Kerstann, Pete Lollar, H. Trent Spencer, Gabriela Denning, Lajos Baranyi, (unknown), Boro Dropulić, Christopher B. Doering	2
6	Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene 2007 ·Blood ·Cary Hsu, (unknown), Cyrille J. Cohen, Zhili Zheng, Keith Kerstann, Juhua Zhou, Paul F. Robbins, Peter D. Peng, Xinglei Shen, (unknown), Cynthia E. Dunbar, David J. Munroe, Claudia Stewart, Kenneth Cornetta, Danny Wangsa, Thomas Ried, Steven A. Rosenberg, Richard A. Morgan	98
7	Modulation by IL-2 of CD70 and CD27 Expression on CD8+ T Cells: Importance for the Therapeutic Effectiveness of Cell Transfer Immunotherapy 2006 ·The Journal of Immunology ·Jianping Huang, Keith Kerstann, Mojgan Ahmadzadeh, Yong F. Li, Mona El‐Gamil, Steven A. Rosenberg, Paul F. Robbins	122
8	Central memory self/tumor-reactive CD8 ⁺ T cells confer superior antitumor immunity compared with effector memory T cells breakdown → 2005 ·Proceedings of the National Academy of Sciences ·Christopher A. Klebanoff, Luca Gattinoni, Parizad Torabi‐Parizi, Keith Kerstann, Adela R. Cardones, Steven E. Finkelstein, Douglas C. Palmer, Paul A. Antony, Sam T. Hwang, Steven A. Rosenberg, Thomas A. Waldmann, Nicholas P. Restifo	752
9	Changes in the Fine Specificity of gp100(209–217)-Reactive T Cells in Patients Following Vaccination with a Peptide Modified at an HLA-A2.1 Anchor Residue 1999 ·The Journal of Immunology ·Timothy M. Clay, Mary Custer, Mark D. McKee, Maria R. Parkhurst, Paul F. Robbins, Keith Kerstann, John R. Wunderlich, Steven A. Rosenberg, Michael I. Nishimura	88

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact